Lilly sees new weight-loss pill approval in early 2026, CEO says
Pills would be more convenient for patients and also easier to manufacture at large scale than other top weight-loss drugs, which require , CEO Dave Ricks said.
Pills would be more convenient for patients and also easier to manufacture at large scale than other top weight-loss drugs, which require , CEO Dave Ricks said.
Kristin Sherman leads startup Kovina Therapeutics, which is still in the early stages of developing ways to stop human papillomavirus infections before cancer develops and to treat HPV cancers after detection.
The findings are consistent with a statewide water study released in August that concluded Indiana has a “plentiful” but unevenly distributed water supply.
The Indiana Family and Social Service Administration’s Office of Medicaid Policy and Planning estimates that 5% to 20% of eligible members would be prescribed weight-loss medications.
The state has spent more than $690 million so far establishing the LEAP Research and Innovation District. Outgoing economic leaders say the project is a huge success, but some political leaders are cautious.
IBJ has reported extensively on numerous projects throughout this year in the core of Indianapolis and across the area—some that made significant progress and others that ground to a halt.
It’s been another busy year in Indiana health care and life sciences, with headlines nearly every week announcing another billion-dollar deal or investment.
Despite tightening revenue, Republican leaders quickly dismissed any notion that 2025 could be the year Indiana ends its prohibition on marijuana.
Ricks—IBJ’s newsmaker of the year in 2023—returns to the newsmaker list in 2024 after a year that included a stock price that skyrocketed to an all-time high of $972 and announcements about big new investments in Lebanon and Ireland.
Two major announcements were Eli Lilly and Co.’s additional $9.8 billion investment into its LEAP Research and Innovation District campus and SK Hynix’s $3.87 billion semiconductor packaging facility at the Purdue Research Park in West Lafayette.
Lilly said the expansion is expected to add 400 full-time jobs for highly skilled workers, including engineers, scientists, operations personnel and lab technicians.
The Indiana Economic Development Corp. inched closer to its vision for its LEAP Research and Innovation District in Lebanon this year with more than $100 million in additional state funding, steps to secure water for the site and additional private investment.
The ongoing progress to develop the planned LEAP Innovation and Research District, a 9,000-acre tech park in Boone County, was among the top local tech stories of 2024.
Lilly’s stock was up slightly in after-hours trading.
Holcomb’s administration has focused its economic strategy on courting new companies and investing in those already here.
After a stunning 703% run-up in price over the past five years, shares of Eli Lilly and Co. have been on a roller-coaster ride since September.
Another win for LEAP and more accountability by public officials are on our wish list.
The FDA had previously said Lilly’s drugs were out of shortage and that making copies must cease in October. Compounders sued, causing the FDA to pause enforcement while it reevaluated its decision.
The Allen Whitehill Clowes Ballroom, an 11,000-square-foot venue expected to open in 2027, will be built on the east side of Clowes Hall.
The state will eventually recoup much of that investment when LEAP land is sold to tenants, officials from the Indiana Economic Development Corp. said.